PCSA Processa Pharmaceuticals, Inc.

BULLISH Impact: 5/10 Insider Cluster (2 insiders)
Horizon weeks Filed Apr 15, 2026 Processed 1mo ago
Insider cluster: 2 insiders, $11K total
Latest settled — T+20d
PCSA ▼ -13.51% at T+20d
LONG call ✗ call lost -13.51% · α vs SPY -19.56% · entry $2.96 → $2.56
Next anchor: T+60d in 26d
Currently $2.17 · -26.69% from $2.96 entry
Entry anchored
Apr 14, 03:55 PM ET
via Databento tick
T+1d
+7.43%
call +7.43% · α +7.18%
$3.18
settled 8w ago
T+5d
+3.72%
call +3.72% · α +2.08%
$3.07
settled 8w ago
T+20d
-13.51%
call -13.51% · α -19.56%
$2.56
settled 5w ago
T+60d
call — · α —
in 26d

Price Chart

Loading chart...

Executive Summary

Two corporate insiders at Processa Pharmaceuticals — the CFO and Chief Development Officer — made open-market purchases totaling approximately $11,235 in the past week, signaling confidence in the company at a time of very low market cap ($8M). The buying is modest in dollar terms but notable given the company's size.

Key Financial Metrics

Direction
buying
Total Value
$11.2K
Insiders
2

Actionable Insight

While the absolute dollar amount is small, the coordinated buying by two C-suite executives at a micro-cap biopharma company may signal positive internal sentiment ahead of potential catalysts. Traders should monitor for upcoming clinical updates or financing news.

Key Facts

  • CFO Russell Skibsted purchased 1,984 shares for $5,892.48 on April 15, 2026.
  • Chief Development Officer Bigora Sian purchased 1,799 shares for $5,343.03 on April 15, 2026.
  • Both purchases were open-market transactions at $2.97 per share.
  • Total cluster value: ~$11,235, representing ~0.14% of the company's $8M market cap.

Financial Impact

$11,235 in insider buying over 7 days, equivalent to 0.14% of market cap

insider sentimentmarket confidence

Risk Factors

  • The total purchase amount is small and may not reflect broad insider conviction.
  • Biopharma stocks at this stage are highly speculative and sensitive to dilution risk.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PCSA-1776459046655
7 reports for PCSA
Performance horizon
83% Hit rate 5 of 6 directional calls best @ T+5▲ +19.60%Mar 31, 2026
Filters
Rows
Reports for PCSA — sortable, filterable
Type Now
Jun 1, 2026
11d ago
Insider Cluster
BULLISH ★ 4/10
$2.92 $2.80▼ −4.11%▼ −3.39%$2.17 (−25.68%)
May 19, 2026
24d ago
Insider Cluster
BULLISH ★ 5/10
$2.61 $2.57▼ −1.72%▼ −1.92%$2.17 (−16.86%)
May 19, 2026
24d ago
Insider Cluster
BULLISH ★ 5/10
$2.61 $2.57▼ −1.72%▼ −1.92%$2.17 (−16.86%)
Apr 30, 2026
6w ago
Insider Cluster
BULLISH ★ 4/10
$2.70 $2.55▼ −5.56%▼ −5.78%$2.17 (−19.63%)
Apr 15, 2026
8w ago
Insider Cluster
BULLISH ★ 5/10
$2.96 $3.18▲ +7.43%▲ +7.18%$2.17 (−26.69%)
Mar 31, 2026
10w ago
Insider Cluster
BULLISH ★ 6/10
$2.53 $2.60▲ +3.09%▲ +2.34%$2.17 (−14.06%)
Mar 31, 2026
10w ago
Insider Cluster
BULLISH ★ 6/10
$2.53 $2.60▲ +3.09%▲ +2.34%$2.17 (−14.06%)
Showing 7 of 7

US Market Status

Market Closed — Opens Mon (47h)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access